No items found.
The business of life sciences R&D is fundamentally shifting – from a focus on approval to a broader view on widespread adoption by providers and payers, from proving value in controlled, clinical settings to demonstrating it in target populations and real-world conditions.
The business of life sciences R&D is fundamentally shifting – from a focus on approval to a broader view on widespread adoption by providers and payers, from proving value in controlled, clinical settings to demonstrating it in target populations and real-world conditions.
ClosedLoop generates explainable predictions using
thousands of auto-generated, clinically relevant contributing factors
Gain insights into the patients that benefit from your products and learn how to distinguish who achieves significantly better outcomes than others.
How much does it improve patient outcomes? Does it outperform alternative therapies? Does it achieve these outcomes at an appropriate value? Which patients are most likely to benefit from it?
Winning is in the details. Success begins with a comprehensive understanding and segmentation of patients. Our comprehensive AI-enriched patient profiles are enriched with more than 2,000 healthcare features and predicted outcomes. Use these AI-enriched profiles to define and gain insights into precision cohorts.
Understand patients’ medical and social needs; identify populations with disproportionate unmet needs, specific barriers to care, or at risk of non-adherence; and gain insights into the non-clinical factors that impact the patient journey and access to therapy.
